title: Dasatinib-induced leukotrichia in a patient with chronic myelogenous leukemia.
authors.forename: Sara
authors.initials: S
authors.lastname: Samimi
authors.forename: Emily
authors.initials: E
authors.lastname: Chu
authors.forename: John
authors.initials: J
authors.lastname: Seykora
authors.forename: Alison
authors.initials: A
authors.lastname: Loren
authors.forename: Carmela
authors.initials: C
authors.lastname: Vittorio
authors.forename: Alain
authors.initials: A
authors.lastname: Rook
authors.forename: Misha
authors.initials: M
authors.lastname: Rosenbach
authors.forename: Ellen J
authors.initials: EJ
authors.lastname: Kim
mesh_terms: D000328:Adult; D000069439:Dasatinib; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006201:Hair Diseases / Q000139:chemically induced* / Q000473:pathology; D018859:Hair Follicle / Q000473:pathology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib